Literature DB >> 26777555

Relationship between Vertebral Artery Hypoplasia and Posterior Circulation Ischemia.

Hidetaka Mitsumura1, Shinji Miyagawa2, Teppei Komatsu2, Toshiaki Hirai2, Yu Kono2, Yasuyuki Iguchi2.   

Abstract

PURPOSE: Vertebral artery hypoplasia (VAH) is a common congenital anatomical variation. In previous reports, it was unclear whether VAH was an independent risk factor for posterior circulation ischemia. The purpose of this study was to evaluate the impact of VAH on posterior circulation ischemia.
METHODS: Subjects were patients with acute ischemic stroke who underwent brain magnetic resonance imaging (MRI) and carotid ultrasonography. Diagnostic criteria for VAH were as follows: (1) Vertebral artery (VA) diameter less than 2.5 mm; (2) VA diameter less than 3.0 mm and a difference in length equal to or greater than 1:1.7; (3) VA diameter less than 3.0 mm, peak systolic velocity less than 40 cm/second, and resistance index value greater than .75. The patients were categorized by the location of the ischemic stroke on MRI as follows: lesion in posterior circulation (P group), lesion in anterior circulation (A group), and multiple lesions in both the anterior and posterior circulations (AP group).
RESULTS: We evaluated 129 consecutive patients. VAH was seen in 39, and VA occlusion was found in 15. The prevalence of VAH in the P group (44.4%) was significantly higher than that in the A + AP group (24.7%, P = .034). Multivariate regression analysis showed that large-artery atherosclerosis (odds ratio, 6.3; 95% confidence interval [CI], 1.3-30.1), posterior circulation ischemia (odds ratio, 12.0; 95% CI, 2.8-51.2), and VAH (odds ratio, 4.2; 95% CI, 1.2-15.0) were independent factors related to VA occlusion.
CONCLUSION: VAH was an independent factor related to VA occlusion. Therefore, VAH likely plays a role in posterior circulation ischemia.
Copyright © 2015 National Stroke Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Vertebral artery hypoplasia; acute ischemic stroke; carotid duplex ultrasound; large-artery atherosclerosis; posterior circulation ischemia; vertebral artery occlusion

Mesh:

Year:  2015        PMID: 26777555     DOI: 10.1016/j.jstrokecerebrovasdis.2015.09.027

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  6 in total

1.  Detection of vessel wall calcifications in vertebral arteries using susceptibility weighted imaging.

Authors:  Lisa C Adams; Sarah M Böker; Yvonne Y Bender; Eva M Fallenberg; Moritz Wagner; Thomas Liebig; Bernd Hamm; Marcus R Makowski
Journal:  Neuroradiology       Date:  2017-07-20       Impact factor: 2.804

2.  Vertebral artery hypoplasia: an innocent lamb or a disguise?

Authors:  Caterina Kulyk; Chiara Voltan; Marialaura Simonetto; Anna Palmieri; Filippo Farina; Francesca Vodret; Federica Viaro; Claudio Baracchini
Journal:  J Neurol       Date:  2018-08-16       Impact factor: 4.849

3.  Variations of transverse foramina in cervical vertebrae: what happens to the vertebral artery?

Authors:  Aristeidis Zibis; Vasileios Mitrousias; Nikolaos Galanakis; Nikoletta Chalampalaki; Dimitrios Arvanitis; Apostolos Karantanas
Journal:  Eur Spine J       Date:  2018-02-17       Impact factor: 3.134

4.  Lesion Topography and Its Correlation With Etiology in Medullary Infarction: Analysis From a Multi-Center Stroke Study in China.

Authors:  Yue-Hui Hong; Li-Xin Zhou; Ming Yao; Yi-Cheng Zhu; Li-Ying Cui; Jun Ni; Bin Peng
Journal:  Front Neurol       Date:  2018-09-27       Impact factor: 4.003

5.  An anatomical investigation of the proximal vertebral arteries (V1, V2) in a select South African population.

Authors:  B R Omotoso; R Harrichandparsad; I G Moodley; K S Satyapal; L Lazarus
Journal:  Surg Radiol Anat       Date:  2021-03-10       Impact factor: 1.246

6.  Clinical Characteristics of Patients with Vertebral Artery Hypoplasia.

Authors:  Marcin Bakalarz; Jacek J Rożniecki; Mariusz Stasiołek
Journal:  Int J Environ Res Public Health       Date:  2022-07-29       Impact factor: 4.614

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.